| abstract |
Methods for using (indazol-5-yl) -pyrazines and (1,3-dihydro-indole-2-one) -pyrazines for treating rho kinase mediated diseases or rho kinase mediated conditions are described herein. includes controlling intraocular pressure and treating glucoma; Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, compositions comprising an effective amount of (indazol-5-yl) -pyrazines and (1,3-dihydro- indole-2-one) -pyrazines, are described herein. |